Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in different ways to stop
the growth of cancer cells, either by killing the cells or by stopping them from dividing.
Darbepoetin alfa may cause the body to make more red blood cells. It is not yet known whether
fludarabine is more effective with or without darbepoetin alfa in treating chronic
lymphocytic leukemia.
PURPOSE: This phase III trial is studying fludarabine to see how well it works when given
together with or without darbepoetin alfa in treating older patients with chronic lymphocytic
leukemia.